Schroder Investment Management Group’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$686K Sell
28,349
-69,558
-71% -$1.65M ﹤0.01% 1060
2025
Q4
$2.6M Sell
97,907
-63,579
-39% -$1.39M ﹤0.01% 849
2025
Q3
$2.78M Sell
161,486
-143,180
-47% -$2.05M ﹤0.01% 869
2025
Q2
$3.8M Sell
304,666
-17,283
-5% -$206K ﹤0.01% 820
2025
Q1
$3.98M Sell
321,949
-15,212
-5% -$207K ﹤0.01% 806
2024
Q4
$4.89M Buy
+337,161
New +$4.71M ﹤0.01% 777

Other funds holding ZYME

Schroder Investment Management Group's ZYME Position: Q1 2026 in Review

Schroder Investment Management Group reduced its Zymeworks (ZYME) stake by 71% in Q1 2026, selling an estimated $1.65M and leaving 28,349 shares worth $686K. The position accounts for ﹤0.01% of the portfolio, ranked #1060.

Schroder Investment Management Group first reported a position in ZYME in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.89M in Q4 2024. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Schroder Investment Management Group held 28,349 shares of Zymeworks worth $686K as of Q1 2026.
  • Schroder Investment Management Group sold 69,558 Zymeworks shares in Q1 2026, an estimated $1.65M.
  • Zymeworks made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q1 2026, its #1060 holding.
  • Schroder Investment Management Group first reported a position in Zymeworks in Q4 2024 and has held it in 6 quarters since.
  • Schroder Investment Management Group's Zymeworks position peaked at $4.89M in Q4 2024.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Schroder Investment Management Group's 13F filing for Q1 2026, filed 14 May 2026.